SCHEMBL25003045

SCHEMBL25003045

N#Cc1c(Cl)cccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)C2CC32)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 17/20 0.54
HTR2A P28223 6/20 0.54
DRD3 P35462 5/20 0.54
HTR1A P08908 4/20 0.54
DRD1 P21728 4/20 0.54
DRD4 P21917 4/20 0.54
HTR2B P41595 3/20 0.54
HTR7 P34969 2/20 0.54
HTR6 P50406 2/20 0.54
DRD5 P21918 2/20 0.54
HTR2C P28335 2/20 0.54
HTR3E A5X5Y0 1/20 0.54
MEN1 O00255 1/20 0.54
MLNR O43193 1/20 0.54
HTR3B O95264 1/20 0.54
ABCB11 O95342 1/20 0.54
ESR1 P03372 1/20 0.54
PGR P06401 1/20 0.54
ADRB2 P07550 1/20 0.54
CHRM2 P08172 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003006 0.90 DRD2 (0.65) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL30839773 0.90 DRD2 (0.65) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25003024 0.89 DRD2 (0.68) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL30839782 0.89 DRD2 (0.68) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25003010 0.88 DRD2 (0.58) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25004008 0.88 DRD2 (0.67) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25004005 0.88 DRD2 (0.67) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25003048 0.87 DRD2 (0.56) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25003014 0.87 DRD2 (0.56) DRD2HTR2ADRD3HTR1ADRD1
SCHEMBL25002997 0.87 DRD2 (0.56) DRD2HTR2ADRD3HTR1ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023011608-A1 REGULATOR CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海枢境生物科技有限公司 2023-02-09 WO disclosed